Clinical Trial Update: Multiple Dose Study of TRx0037 [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose trial of TRx0037 for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TRx0037

Snippet

Sponsor: TauRx Therapeutics Ltd | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED